MRIGlobal is working toward a world without cancer.
MRIGlobal operates the National Cancer Institute’s Anti-Cancer Chemicals and Pharmaceutical Formulations Analysis Program. Under the program, MRIGlobal performs analyses that support the development of anti-cancer chemicals and pharmaceuticals that are typically in pre-approval phases, and MRIGlobal’s analyses are performed to meet requirements of the U.S. Food and Drug Administration.
MRIGlobal recently won a new contract for the program, the 12th consecutive contract from the National Cancer Institute, a program that has been in place with MRIGlobal since 1969.
In the 43 years of operating the program, MRIGlobal has completed more than 2,000 analytical reports on small organic molecules, complex antibiotics, proteins and other compounds.
Read the Press Release.
Learn more about the Life Sciences work being done at MRIGlobal.